Amylyx Pharmaceuticals logo

Regional Scientific Director (MSL), Midwest

Amylyx Pharmaceuticals

Chicago, IL; Minneapolis, MN; Milwaukee, WIHybridPosted 1 day ago$228,000 - $257,000/year
Full TimeSenior LevelMedical AffairsPharmaceutical
Original posting ↗

Summary

Our Regional Scientific Director, with support and guidance from peers and leadership, will serve as a field based scientific, medical expert to the medical/academic community and is responsible for establishing and maintaining relationships with Key Opinion Leaders (KOLs) and Health Care Providers/Professionals (HCPs) to ensure the appropriate dissemination of clinical and scientific information regarding Amylyx's compounds in a timely, ethical and stakeholder-focused manner. The RSD will contribute to shaping the medical plan by providing external stakeholders' insights and contribute to the design and execution of the Medical Affairs strategy and plan.

Job description

The Opportunity

Our Regional Scientific Director, with support and guidance from peers and leadership, will serve as a field based scientific, medical expert to the medical/academic community and is responsible for establishing and maintaining relationships with Key Opinion Leaders (KOLs) and Health Care Providers/Professionals (HCPs) to ensure the appropriate dissemination of clinical and scientific information regarding Amylyx's compounds in a timely, ethical and stakeholder-focused manner. The RSD will contribute to shaping the medical plan by providing external stakeholders' insights and contribute to the design and execution of the Medical Affairs strategy and plan.

Responsibilities

  • Respond to questions from KOLs and HCPs with fair and balanced scientific, medical responses
  • Manage questions around safety, adherence and off label data on Amylyx's products
  • Provide ongoing medical/scientific education to Amylyx's field and HQ teams
  • Support clinical initiatives including site identification, trial recruitment, registry and presentation of final approved data
  • Conduct regular and extensive reviews of literature, develop presentations and assist with publications and medical communications
  • Develop and execute prioritized plans for KOLs/institutions/societies
  • Develop and execute a strategic, innovative territory plan of medical and therapeutic area objectives, in collaboration with Scientific Communication, Real World Evidence and medical directors
  • Represent Amylyx medical affairs at medical congresses, educating on Amylyx's pipeline products, collecting competitive intelligence and reviewing data
  • Identify and support data generation projects, content development and review of scientific education materials, clinical site participation and internal publications
  • Support commercial team functions including facilitating internal training, speaker training programs, internal scientific material review and competitive insights into therapeutic area planning
  • Conceptual and practical knowledge of local and regional payers within the geography and understands the relationships between those plans and patient care delivery in the region
  • Maintain compliance with all internal and external legal and regulatory guidelines

Required Qualifications

  • Advanced degree (e.g., PhD, PharmD, DNP, DHSc, or MD)
  • 8 plus years experience as a field medical scientist (Medical Science Liaison) preferred OR relevant experience in medical affairs: Regional Scientific Director
  • 5 to 8 years as a field medical scientist (Medical Science Liaison) preferred OR relevant experience in medical affairs: Associate, Regional Scientific Director
  • Experience driving medical affairs projects [data generation projects, abstracts, education materials]
  • Excellent presentation, communication, and project management skills
  • Ability to understand and effectively communicate scientific/medical benefits of pharmaceutical products to the medical community
  • Strong data analysis skills
  • Demonstrated ability to effectively facilitate meetings
  • Ability to work independently and function successfully as a team member
  • Must be able to travel within assigned region 3-4 days per week including overnight stays
  • Must have a valid driver's license

Preferred Qualifications

  • Endocrinology and rare disease experience, Neuromuscular disorders experience beneficial
  • Well-established networks with endocrinology KOLs

Requirements

  • Advanced degree (e.g., PhD, PharmD, DNP, DHSc, or MD)
  • 8 plus years experience as a field medical scientist (Medical Science Liaison) preferred OR relevant experience in medical affairs: Regional Scientific Director
  • 5 to 8 years as a field medical scientist (Medical Science Liaison) preferred OR relevant experience in medical affairs: Associate, Regional Scientific Director
  • Experience driving medical affairs projects (data generation projects, abstracts, education materials)
  • Excellent presentation, communication, and project management skills
  • Ability to understand and effectively communicate scientific/medical benefits of pharmaceutical products to the medical community
  • Strong data analysis skills
  • Demonstrated ability to effectively facilitate meetings
  • Ability to work independently and function successfully as a team member
  • Must be able to travel within assigned region 3-4 days per week including overnight stays
  • Must have a valid driver's license
  • Endocrinology and rare disease experience preferred
  • Neuromuscular disorders experience beneficial
  • Well-established networks with endocrinology KOLs preferred

Benefits

  • Performance-based bonuses
  • Equity awards
  • Comprehensive benefits package

Company overview

Amylyx Pharmaceuticals is a clinical-stage pharmaceutical company based in Cambridge, Massachusetts, founded in 2013 by co-CEOs Josh Cohen and Justin Klee. The company specializes in developing novel therapies for neurodegenerative diseases with high unmet medical needs, with a particular focus on amyotrophic lateral sclerosis (ALS), Wolfram syndrome, and post-bariatric hypoglycemia. Amylyx's lead investigational therapy, AMX0035, received FDA approval for ALS treatment under the brand name RELYVRIO in September 2022. The company employs a rigorous scientific approach to target multiple pathological pathways in neurodegeneration, with additional pipeline candidates including avexitide for metabolic disorders and AMX0114, an antisense oligonucleotide targeting calpain-2 for ALS. With a team of 201-500 employees, Amylyx combines therapeutic development expertise with commercialization capabilities to address some of medicine's most challenging conditions.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.